# Embecta Corp.: Form 10-Q for the period ended Jun 30, 2026

- Company: [Embecta Corp.](/companies/embc.md) (CIK 1872789)
- Form: 10-Q
- Filed: 2026-08-07
- Accepted by EDGAR: Aug 7, 2026, 14:28 ET
- Period: 2026-06-30
- Accession: 0001872789-26-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1872789/000187278926000033/embc-20260630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1872789/000187278926000033/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-04-01 to 2026-06-30 | $271.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2025-10-01 to 2026-06-30 | $754.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2026-04-01 to 2026-06-30 | $118.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2025-10-01 to 2026-06-30 | $311.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2026-04-01 to 2026-06-30 | $153.3m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2025-10-01 to 2026-06-30 | $442.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2026-04-01 to 2026-06-30 | $5.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2025-10-01 to 2026-06-30 | $15.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2026-04-01 to 2026-06-30 | $78.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2025-10-01 to 2026-06-30 | $232.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2026-04-01 to 2026-06-30 | $48.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2025-10-01 to 2026-06-30 | $167.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2026-04-01 to 2026-06-30 | $6.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2025-10-01 to 2026-06-30 | $34.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-04-01 to 2026-06-30 | $21.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2025-10-01 to 2026-06-30 | $61.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2025-10-01 to 2026-06-30 | $1.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-04-01 to 2026-06-30 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2025-10-01 to 2026-06-30 | $1.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-04-01 to 2026-06-30 | 58,512,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2025-10-01 to 2026-06-30 | 59,580,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2025-10-01 to 2026-06-30 | $90.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2025-10-01 to 2026-06-30 | $2.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2025-10-01 to 2026-06-30 | $18.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2025-10-01 to 2026-06-30 | $8.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-06-30 | $214.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-06-30 | $705.1m | us-gaap:AssetsCurrent |
| Total assets | at 2026-06-30 | $1.27bn | us-gaap:Assets |
| Current liabilities | at 2026-06-30 | $419.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2026-06-30 | $1.32bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2026-06-30 | $139.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2026-06-30 | −$612.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1872789/000187278926000033/embc-20260630.htm

Filed Aug 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001872789-26-000033. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.